The duchenne muscular dystrophy (DMD) drugs market is expected to grow at a CAGR of 12.1% during the forecast period of 2025 to 2033, due to advancements in medical research, increased awareness of the disease, and the development of innovative therapeutic approaches. Duchenne Muscular Dystrophy, a severe type of muscular dystrophy, primarily affects boys and leads to progressive muscle degeneration and weakness. The market for DMD drugs is driven by the urgent need for effective treatments that can slow down disease progression, improve the quality of life for patients, and potentially offer a cure.
The cell line development market is expected to grow at a CAGR of 13.3% during the forecast period of 2025 to 2033, due to advancements in biotechnology and an increasing demand for biopharmaceuticals. Cell lines are essential for producing biologics, which include vaccines, therapeutic proteins, and monoclonal antibodies. The cell line development market is poised for significant growth driven by the rising demand for biopharmaceuticals, advancements in cell line development technologies, and increasing investment in research and development.
Medical foods are specially formulated products designed for the dietary management of a disease or condition with unique nutritional needs that cannot be met by a regular diet alone. They are not mere diet foods or traditional supplements. Instead, they address specific dietary deficiencies related to certain diseases or conditions. These products are intended to be consumed or administered under the guidance of a physician. The U.S. Food and Drug Administration (FDA) provides specific criteria that products must meet to be classified as medical foods.
The insect growth regulator (IGR) market encompasses products and solutions that impede the lifecycle of insects without using traditional insecticides. IGRs work by disrupting the development of insects at various stages of their life cycle, preventing them from reaching maturity and reproducing. These regulators are often classified into two types: juvenoids, which mimic juvenile hormones and prevent insects from maturing, and chitin synthesis inhibitors, which disrupt the formation of chitin, an essential component of an insect’s exoskeleton. The insect growth regulator market is projected to expand at a compound annual growth rate (CAGR) of 4.5%.
The gummy market comprises edible candies that are gelatin-based chewable sweets. Gummies come in a wide variety of shapes, sizes, and flavors, often resembling items from the natural world, such as bears, worms, fruits, and other objects. These products are popular across all age groups but are particularly favored by children. Gummies are not only consumed for pleasure but are also increasingly available as vehicles for nutritional supplements, including vitamins, minerals, and other functional ingredients like fiber and probiotics, expanding their appeal to health-conscious consumers. The gummy market is projected to grow at a CAGR of 6.4% over the forecast period.
